Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

Siemens features new methods for pinpointing, treatment tumors

Siemens introduced new solutions in adaptive radiation therapy,which uses diagnostic quality images to adapt treatment delivery basedon the actual state of what is happening at and around the tumor site,at the 50th annual meeting of the American Society for TherapeuticRadiology and Oncology (ASTRO) in Boston last week.

GE unveils MRI oncology package, archiving device

GE Healthcare highlighted the launch of a new MRI oncology packageduring the American Society for Therapeutic Radiology and Oncologys(ASTRO) 50th annual meeting in Boston last week.

Calypso showcases new trial start, partnerships

Calypso Medical kicked off the start of the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston last week with the start of new clinical trials, while promoting new research grants and industry partnerships.

Xoft focuses on point-of-care access with electronic radiation therapy

Xoft showcased early clinical trial results, as well as its growingsuite of oncology treatment technologies, during at the 50th AmericanSociety for Therapeutic Radiology and Oncology (ASTRO) annual meeting.

Calypso starts IMRT study to track tissue motion

Calypso Medical Technologies announced the start of its PROBE clinical study to guide delivery of intensity modulated radiation therapy (IMRT) in prostate cancer patients following radical prostatectomy at the 50th American Society for Therapeutic Radiology and Oncology (ASTRO).

Cancer recurrence in women with DCIS isn?t determined by age

BOSTON—A new study rebuffs conventional thinking that young women with ductalcarcinoma in situ (DCIS) are presumed more likely to have recurrencesthan older women with the same diagnosis, according to researchpresented Wednesday at the 50th annual meeting of the American Societyfor Therapeutic Radiology and Oncology (ASTRO).

Hormone therapy before brachytherapy increases mortality in older patients

BOSTON—Men over 70 years of age with early-stage prostate cancer have20 percent higher mortality if they are treated with hormone therapybefore being treated with brachytherapy, compared to men who aretreated with brachytherapy alone, according to a large cohort studypresented Tuesday at the 50th annual meeting of the American Societyfor Therapeutic Radiology and Oncology (ASTRO).

Shorter PSA doubling time should prompt earlier hormone therapy

BOSTON—Early-stage prostate cancer treated with radiation therapyshould begin hormone therapy immediately if their PSA level risesquickly and doubles within six months after treatment; however patientsshould forego hormones if PSA levels do not rise as quickly, accordingto research presented Tuesday at the 50th annual meeting of theAmerican Society for Therapeutic Radiology and Oncology (ASTRO).

Displaying 2369 - 2376 of 2553

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.